Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1651 (LINC01651) is a human gene encoding a long non-coding RNA molecule. It does not code for a protein, but belongs to a class of RNAs called long non-coding RNAs (lncRNAs), which are known to play regulatory roles in gene expression and cellular functions[1][3][5][7][9][13][11]. The transcript is mapped to chromosome 22 (21,354,563-21,358,067, forward strand)[5]. LINC01651 is listed in databases such as HGNC, Ensembl, and NCBI Gene, and is also known as KB-1183D5.18[1][3][5][7][9][13]. While lncRNAs have been implicated broadly in cancer biology and regulation of cellular processes[14], there is no direct, curated evidence that LINC01651 itself is a validated therapeutic target, biomarker, or has documented drug interactions or established safety concerns in clinical use. It is classified primarily as a non-coding RNA rather than a receptor, enzyme, transporter, transcription factor, or other druggable molecular target[9][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1651 (LINC01651).